FTXH.US First Trust Nasdaq Pharmaceuticals ETF

ETF Healthcare Equity First Trust USA Stocks
- USD
No recent price
Total assets
1.20B
Expense ratio
0.57%
Dividend yield
0.67%
1-year return
+41.34%
Holdings
50
Since
2016

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does FTXH.US invest in?

  • Mostly US stocks (94.6%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (99.6%)
  • Top 3 holdings: 23.0% of the fund

Asset allocation

  • US stocks 94.6%
  • Non-US stocks 0.6%
  • Cash 0.0%

Top holdings

  • Eli Lilly and Company 7.97%
  • AbbVie Inc 7.89%
  • Johnson & Johnson 7.09%
  • Pfizer Inc 6.90%
  • Merck & Company Inc 6.69%
All holdings, sectors and regions

First Trust Nasdaq Pharmaceuticals ETF performance

Sharpe ratio 1.37
This year
+35.18%
1 year
+41.34%
3 years
+23.17%
5 years
+11.44%

Volatility 15.0% over 1 year and 14.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

FTXH.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About First Trust Nasdaq Pharmaceuticals ETF

The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Full fund profile